Tagged: Impact Assessments issued in 2012

The introduction of independent prescribing by physiotherapists has potential to improve access to medicines by hard to reach and marginalised groups including the homeless, travellers and offenders and to streamline care for other groups – particularly for older people and … Read more → – Impact assessment on proposal to introduce independent prescribing by physiotherapists (IA 1018)

The introduction of independent prescribing by podiatrists has potential to improve access to medicines by hard to reach and marginalised groups including the homeless, travellers and offenders and to streamline care for other groups – particularly for older people and … Read more → – Impact Assessment on proposals to introduce independent prescribing by podiatrists (IA 1019)

This initiative introduced in 2008, through Directions to NHS Primary Care Trusts (PCTs), a charging regime for applicants applying to provide NHS pharmaceutical services as a contribution towards the costs the NHS incurs in dealing with such applications. This IA … Read more → – Impact Assessment Fees for Pharmaceutical Services (IA 5098)

To ensure a proportionate regulatory regime which encourages the supply of NHS pharmaceutical services without excessive provision in areas already adequately meeting demand, to ensure the benefits of new entry outweigh costs and to align provision more transparently with local … Read more → – Impact Assessment for Regulations under the Health Act 2009: Control of Entry and Exit in the NHS Pharmaceutical Market (IA 5035)

The impact assessment focuses on the proposal to establish Health Education England as an NDPB (currently established as a Special Health Authority). Provisions to enable this change are contained within the draft Care and Support Bill. Read Impact Assessment Health … Read more → – Impact Assessment on proposals for establishing Health Education England (IA 8040)

The impact assessment focuses on the proposal to establish the Health Research Authority as an NDPB (currently established as a Special Health Authority). Provisions to enable this change are contained within the draft Care and Support Bill. Read Impact assessment … Read more → – Impact Assessment on proposals for establishing the Health Research Authority (IA 9517)

This impact assessment was produced with regard to measuring the impact of consolidating and simplifying the fragmented legislation regulating medicines. Read Impact Assessment: Consolidation of UK medicines legislation (PDF, 119K) Read the Regulatory Policy Committee opinion (PDF, 66K)